journal
https://read.qxmd.com/read/39382779/camptothecin-and-its-derivatives-advancements-mechanisms-and-clinical-potential-in-cancer-therapy
#1
REVIEW
Madhu Kamle, Shikha Pandhi, Sadhna Mishra, Sreejani Barua, Anju Kurian, Dipendra Kumar Mahato, Prasad Rasane, Dietrich Büsselberg, Pradeep Kumar, Daniela Calina, Javad Sharifi-Rad
Camptothecin (CPT), an alkaloid isolated from the Camptotheca tree, has demonstrated significant anticancer properties in a range of malignancies. However, its therapeutic efficacy is limited by its hydrophobicity, poor bioavailability, and systemic toxicity. Derivatives, analogues, and nanoformulations of CPT have been synthesized to overcome these limitations. The aim of this review is to comprehensively analyze existing studies to evaluate the therapeutic efficacy, mechanistic aspects, and clinical potential of CPT and its modified forms, including derivatives, analogues, and nanoformulations, in cancer treatment...
October 9, 2024: Medical Oncology
https://read.qxmd.com/read/39377887/progress-in-lymphedema
#2
REVIEW
Robert A Smith
A century ago, the first description of secondary lymphedema resulting from mastectomy was published in the medical literature. For most of the remaining twentieth century, evidence about cancer treatment related lymphedema grew slowly, and mostly through clinicians who wished to understand its causes, natural-history, and post-treatment risks, as well as from clinicians involved with its treatment. In the late 1990s, there was growing recognition that there were large gaps in our understanding of predisposing and post-treatment risks of onset, the near and long-term prevalence of lymphedema, and how to educate patients...
October 8, 2024: Medical Oncology
https://read.qxmd.com/read/39375229/regulation-of-autophagy-by-non-coding-rnas-in-human-glioblastoma
#3
REVIEW
Mehran Molavand, Niloufar Ebrahimnezhade, Arash Kiani, Bahman Yousefi, Ahmad Nazari, Maryam Majidinia
Glioblastoma, a lethal form of brain cancer, poses substantial challenges in treatment due to its aggressive nature and resistance to standard therapies like radiation and chemotherapy. Autophagy has a crucial role in glioblastoma progression by supporting cellular homeostasis and promoting survival under stressful conditions. Non-coding RNAs (ncRNAs) play diverse biological roles including, gene regulation, chromatin remodeling, and the maintenance of cellular homeostasis. Emerging evidence reveals the intricate regulatory mechanisms of autophagy orchestrated by non-coding RNAs (ncRNAs) in glioblastoma...
October 7, 2024: Medical Oncology
https://read.qxmd.com/read/39369172/comparative-evaluation-of-anticancer-potential-of-spilanthes-paniculata-leaf-and-flower-essential-oil-using-annexin-v-and-orosphere-formation-in-oral-cancer-cell-line
#4
COMPARATIVE STUDY
Soumya Subhashree Satapathy, Ruchi Bhuyan, Arun Kumar Pradhan, Soumya Satpathy, Nihar Ranjan Panda, Sanat Kumar Bhuyan
Spilanthes paniculata, a member of the Asteraceae family, is predominantly used as a traditional remedy in addressing oral ailments, particularly gum infections and sore throat. The flowers are chewed to alleviate toothache immediately. This study evaluated a comparison between the essential oils of leaf and flower derived from Spilanthes paniculata targeting the SCC9 oral cell lines using in vitro and in silico approaches. The anticancer activity was performed through an MTT assay, apoptosis assays using annexin V and orospheres formation assays...
October 5, 2024: Medical Oncology
https://read.qxmd.com/read/39368002/ddx3x-dynamics-glioblastoma-s-genetic-landscape-therapeutic-advances-and-autophagic-interplay
#5
REVIEW
Arpit Sharma, Shruti S Raut, Alok Shukla, Shivani Gupta, Amit Singh, Abha Mishra
Glioblastoma is one of the most aggressive and deadly forms of cancer, posing significant challenges for the medical community. This review focuses on key aspects of Glioblastoma, including its genetic differences between primary and secondary types. Temozolomide is a major first-line treatment for Glioblastoma, and this article explores its development, how it works, and the issue of resistance that limits its effectiveness, prompting the need for new treatment strategies. Gene expression profiling has greatly advanced cancer research by revealing the molecular mechanisms of tumors, which is essential for creating targeted therapies for Glioblastoma...
October 5, 2024: Medical Oncology
https://read.qxmd.com/read/39352579/letter-to-the-editor-comment-on-citalopram-an-antipsychotic-agent-induces-g1-g0-phase-cell-cycle-arrest-and-promotes-apoptosis-in-human-laryngeal-carcinoma-hep-2-cells
#6
LETTER
https://read.qxmd.com/read/39352464/centromeres-in-cancer-unraveling-the-link-between-chromosomal-instability-and-tumorigenesis
#7
REVIEW
Mohsen Karami Fath, Ahmad Nazari, Noushin Parsania, Paria Behboodi, Seyedeh Sara Ketabi, Pegah Razmjouei, Farnoosh Farzam, Seyyed-Ghavam Shafagh, Mohsen Nabi Afjadi
Centromeres are critical structures involved in chromosome segregation, maintaining genomic stability, and facilitating the accurate transmission of genetic information. They are key in coordinating the assembly and help keep the correct structure, location, and function of the kinetochore, a proteinaceous structure vital for ensuring proper chromosome segregation during cell division. Abnormalities in centromere structure can lead to aneuploidy or chromosomal instability, which have been implicated in various diseases, including cancer...
October 1, 2024: Medical Oncology
https://read.qxmd.com/read/39352436/the-impact-of-trifolium-pratense-extract-on-apoptosis-and-autophagy-in-nalm-6-cells-implications-for-b-all-intervention
#8
JOURNAL ARTICLE
Vida Shirani Asl, Hassan Rafieemehr, Gholamhossein Tamaddon
B-cell acute lymphoblastic leukemia (B-ALL), a prevalent malignancy predominantly affecting children, poses challenges such as drug resistance and cytotoxicity despite available treatment methods. The persistence of these challenges underscores the necessity for innovative therapeutic approaches to enhance efficacy. Natural compounds derived from plants, recognized for their potential to inhibit cancer cell growth, have drawn attention. Trifolium pratense extract, known for its significant anticancer properties in previous studies, was the focus of this investigation...
October 1, 2024: Medical Oncology
https://read.qxmd.com/read/39352425/unraveling-the-role-of-epha2-in-regulating-migration-and-immunomodulation-processes-in-cervical-cancer-exploring-the-synergic-effect-of-17%C3%AE-estradiol-on-cancer-progression
#9
JOURNAL ARTICLE
P P Mubthasima, Anbarasu Kannan
Cervical cancer remained among the most prevalent cancers in women. Erythropoietin-producing hepatocellular A2 (EPHA2) is overexpressed in many cancers, including cervical cancer, and the mechanism by which it regulates cervical cancer progression is not yet fully understood. Exosomes are extracellular vesicles that carry information in the form of biomolecules, deliver it to the recipient cell, and play a vital role in cellular communication. 17β-Estradiol is the natural female steroid hormone with the greatest estrogenic activity, and it induces cell death in cancer...
October 1, 2024: Medical Oncology
https://read.qxmd.com/read/39331195/gamma-butyrobetaine-hydroxylase-bbox1-exerts-suppressive-effects-on-hepg2-hepatoblastoma-cells
#10
JOURNAL ARTICLE
Yuling Zhan, Xiang Dong, Minghui Yang, Suwan Li, Mingrui Ou, Yuanyuan Wang, Yu Gao
Gamma-butyrobetaine hydroxylase (BBOX1) plays a pivotal role in catalyzing the final stage of L-carnitine biosynthesis. Recently, increasing number of studies have reported that BBOX1 is weakly expressed in tumor cells and exhibits antitumor activity. The role of BBOX1 in Hepatoblastoma (HB) has yet to be determined. To substantiate this, we have investigated BBOX1 expression and its clinical relevance in HB, and explored how BBOX1 might inhibit the occurrence and development of HB. The GSE104766 and GSE131329 datasets were used to screen for the core gene BBOX1 in HB and to analyze differences in expression between hepatoblastoma and normal tissues...
September 27, 2024: Medical Oncology
https://read.qxmd.com/read/39320608/personalized-treatment-approach-for-her2-positive-metastatic-breast-cancer
#11
REVIEW
Prashant Pandey, Rishabh Chaudhary, Devika Tripathi, Kousalya Lavudi, Kamal Dua, Michael Weinfeld, Afsaneh Lavasanifar, P S Rajinikanth
Breast cancer (BC) is a leading global concern for women, with 30% being HER2-positive cases linked to poorer outcomes. Targeted therapies like trastuzumab deruxtecan (T-DXd), trastuzumab, pertuzumab, and T-DM1 have revolutionized HER2-positive metastatic breast cancer (MBC) treatment. Although these therapies have improved MBC management and patient outcomes, resistance can develop, reducing effectiveness. Personalized strategies based on tumor characteristics offer hope for better responses and longer outcomes...
September 25, 2024: Medical Oncology
https://read.qxmd.com/read/39320578/analysis-of-the-mechanisms-underlying-the-anticancer-and-biological-activity-of-retinoic-acid-and-chitosan-nanoparticles-containing-retinoic-acid
#12
JOURNAL ARTICLE
Murat Dogan
Retinoic acid (RA) has been shown in earlier investigations to have anticancer properties in various cancer cells. RA's effect on breast cancer treatment remains uncertain, though. This study investigated whether RA and chitosan nanoparticles (NPs) loaded with RA could be harmful to the MCF-7 cell line. In this study, NPs with RA were used in characterization tests. Using ELISA kits, the amounts of 8-okso-2'-deoksiguanozin (8-oxo-dG), BCL-2, Bcl-2-Associated X-protein (Bax), cleaved Poly (ADP-ribose) polymerases (PARP), total oxidant and antioxidant, and cleaved caspase-3 capacities were determined...
September 25, 2024: Medical Oncology
https://read.qxmd.com/read/39316248/the-role-of-molecular-biomarkers-in-recurrent-glioblastoma-trials-an-assessment-of-the-current-trial-landscape-of-genome-driven-oncology
#13
JOURNAL ARTICLE
Mark P van Opijnen, Filip Y F de Vos, Edwin Cuppen, Marjolein Geurts, Sybren L N Maas, Marike L D Broekman
For glioblastoma patients, the efficacy-targeted therapy is limited to date. Most of the molecular therapies previously studied are lacking efficacy in this population. More trials are needed to study the actual actionability of biomarkers in (recurrent) glioblastoma. This study aimed to assess the current clinical trial landscape to assess the role of molecular biomarkers in trials on recurrent glioblastoma treatment. The database ClinicalTrials.gov was used to identify not yet completed clinical trials on recurrent glioblastoma in adults...
September 24, 2024: Medical Oncology
https://read.qxmd.com/read/39316239/vaccine-based-therapeutic-interventions-in-lung-cancer-management-a-recent-perspective
#14
REVIEW
Dhruv Sanjay Gupta, Daksh Sanjay Gupta, Nosheen Kamruddin Abjani, Yash Dave, Ketaki Apte, Ginpreet Kaur, Damandeep Kaur, Adesh Kumar Saini, Ujjawal Sharma, Shafiul Haque, Hardeep Singh Tuli
The incidence of lung cancer continues to grow globally, contributing to an ever-increasing load on healthcare systems. Emerging evidence has indicated lowered efficacy of conventional treatment strategies, such as chemotherapy, surgical interventions and radiotherapy, prompting the need for exploring alternative interventions. A growing focus on immunotherapy and the development of personalized medicine has paved the way for vaccine-based delivery in lung cancer. With various prominent targets such as CD8+ T cells and PD-L1, immune-targeted, anti-cancer vaccines have been evaluated in both, pre-clinical and clinical settings, to improve therapeutic outcomes...
September 24, 2024: Medical Oncology
https://read.qxmd.com/read/39312103/comment-on-gemcitabine-pi3kinase-akt-pathway-inhibition-and-radiation-in-human-glioma-cell-lines-by-m-s-elnaggar-et-al-1
#15
LETTER
M B Balaji, Neha Brahma, S Vimal
The combination of gemcitabine, PI3K-Akt pathway inhibitors, and radiation in human glioma cell lines shows potential to enhance radiation sensitivity in aggressive brain tumors. Inhibiting the overactive PI3K-Akt pathway may increase tumor vulnerability to treatment. However, variability in responses among different glioma cell lines highlights the need for personalized approaches. Future research should focus on identifying biomarkers to tailor treatment for individual patients. Additionally, addressing safety concerns and the challenges of translating preclinical findings into clinical practice is crucial...
September 23, 2024: Medical Oncology
https://read.qxmd.com/read/39312100/letter-to-the-editor-for-the-article-how-mitochondrial-dynamics-imbalance-affects-the-progression-of-breast-cancer-a-mini-review
#16
LETTER
Yu Zhang, Lexin Wang, Gang Huang, Hao Chi
No abstract text is available yet for this article.
September 23, 2024: Medical Oncology
https://read.qxmd.com/read/39312041/comment-on-2-methoxyestradiol-sensitizes-tamoxifen-resistant-mcf-7-breast-cancer-cells-via-downregulating-hif-1%C3%AE
#17
LETTER
Hethesh Chellapandian, Sivakamavalli Jeyachandran
This study investigates the potential of 2-methoxyestradiol (2-ME) to overcome tamoxifen (TAM) resistance in MCF-7 breast cancer cells by downregulating hypoxia-inducible factor 1 alpha (HIF-1α). Through a series of in vitro experiments, the authors demonstrate that combining 2-ME with TAM enhances the cytotoxic effects on resistant cells, increases apoptosis markers, and reduces cholesterol and triglyceride levels. While the findings highlight a promising therapeutic approach, the lack of in vivo or clinical data limits direct clinical application...
September 23, 2024: Medical Oncology
https://read.qxmd.com/read/39289260/incidence-of-lymphedema-related-to-various-cancers
#18
REVIEW
Marie-Eve Letellier, Marize Ibrahim, Anna Towers, Geneviève Chaput
Cancer-related lymphedema (CRL) lacks internationally accepted definition and diagnostic criteria. The accurate incidence of CRL is therefore a challenge and the condition is likely underreported. Patients treated for cancer can develop CRL as a result of surgery, chemotherapy, and/or radiotherapy, which can lead to considerable psychosocial and physical morbidity, and decreased quality of life. Determining CRL incidence is crucial to inform care access and resource allocation, to best support patients affected by this lifelong condition...
September 17, 2024: Medical Oncology
https://read.qxmd.com/read/39259412/the-sirt1-nrf2-pathway-is-a-key-factor-for-drug-therapy-in-chemotherapy-induced-cardiotoxicity-a-mini-review
#19
REVIEW
Suleiman Ibrahim Shelash Mohammad, Asokan Vasudevan, Felix Oghenemaro Enwa, Jaya Bansal, Mamata Chahar, Mamdouh Eldesoqui, Muhammad Ikram Ullah, Zhanna R Gardanova, Hanen Mahmod Hulail, Ahmed Hussein Zwamel
The likelihood of survival for cancer patients has greatly improved due to chemotherapy medicines. However, these antitumor agents might also have unfavorable effects on the cardiovascular system, which could result in sudden or gradual cardiac failure. The production of free radicals that result in oxidative stress appears to be the key mechanism by which chemotherapy-induced cardiotoxicity (CIC) happens. Reports suggest that the Sirtuin-1 (Sirt1)/Nuclear factor E2-associated factor 2 (Nrf2) signaling pathway has been considered an alternative path for counteracting cardiotoxicity by suppressing oxidative stress, inflammation, and apoptosis...
September 11, 2024: Medical Oncology
https://read.qxmd.com/read/39240415/lipid-metabolism-reprogramming-in-renal-cell-carcinomas
#20
REVIEW
Mustafa Khalid Abduljabbar, Mohammed Merza, Abdulqader Aziz, Soumya V Menon, Mandeep Kaur, Zafar Aminov, Safia Obaidur Rab, Ahmed Hjazi, Yasser Fakri Mustafa, Benien C Gabel
This study investigates the intricate mechanisms underlying the correlation between elevated consumption of harmful fats and the onset of kidney malignancies. The rise in global obesity rates has been accompanied by an increased prevalence of renal cancers, prompting an exploration into the molecular pathways and biological processes linking these phenomena. Through an extensive review of current literature and clinical studies, we identify potential key factors contributing to the carcinogenic influence of harmful fats on renal tissues...
September 6, 2024: Medical Oncology
journal
journal
32014
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.